ADGM Adagio Medical Holdings, Inc - Common Stock
$0,63
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$0–$3
12% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$3
+429% upside
P/E (TTM)
-0.7
ROE
—
Nettogewinnmarge
—
ADGM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.63
Marktkapitalisierung
—
P/E (TTM)
-0.7
EPS (TTM)
$-1.51
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$0 – $3
ADGM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2023-12-31
→
2025-12-31
EPS
$-1.51
2023-12-31
→
2025-12-31
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ADGM
Peer-Median
P/E (TTM)
-0.7
27.5
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ADGM
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ADGM
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ADGM
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ADGM
Peer-Median
ADGM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 2 22,2%
- Kauf 6 66,7%
- Halten 1 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
3 Analysten · 2026-08-15
Median
$3.00
Mittelwert
$3.33
← Unter allen Zielen
$0.63
Tief
$3.00
Hoch
$4.00
Median-Ziel
$3.00
+375,9%
Mittelwert-Ziel
$3.33
+428,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.07%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.31 | $-0.30 | -0.01% |
| 31. Dezember 2025 | $-0.16 | $-0.32 | 0.16% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ADGM | — | -0.7 | — | — | — | — |
| CTSO | — | -4.9 | 4.1% | — | — | — |
| NMTC | — | -9.9 | 163.5% | — | — | — |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| ICU | — | — | — | — | — | — |
| MODD | $25M | -0.4 | — | — | -260.0% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | · | $300.0K | |
| Cost of Revenue | $684.0K | · | $1M | |
| R&D Expense | $11M | · | $15M | |
| SG&A Expense | $11M | · | $12M | |
| Operating Expenses | $22M | · | $28M | |
| Operating Income | $-22M | · | $-28M | |
| Interest Income | $477.0K | · | $3.0K | |
| Other Non-op | $195.0K | · | $-20.0K | |
| Pretax Income | $-25M | · | $-37M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-25M | · | $-37M | |
| EPS (Basic) | $-1.51 | · | $-48.16 | |
| EPS (Diluted) | $-1.51 | · | $-48.16 | |
| Shares (Basic) | 16,577,126 | · | 759,814 | |
| Shares (Diluted) | 16,577,126 | · | · |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $17M | $21M | $1M | |
| Receivables | · | $35.0K | $71.0K | |
| Inventory | $2M | $3M | $3M | |
| Prepaid Expense | $989.0K | $2M | $232.0K | |
| Other Current Assets | $316.0K | $222.0K | $177.0K | |
| Current Assets | $20M | $25M | $5M | |
| PP&E (Net) | $2M | $2M | $1M | |
| PP&E (Gross) | $4M | $5M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | |
| Goodwill | $14M | $14M | $0 | |
| Intangibles | $7M | $7M | $0 | |
| Other Non-current Assets | $3.0K | $14.0K | $23.0K | |
| Total Assets | $43M | $48M | $7M | |
| Accounts Payable | $1M | $3M | $4M | |
| Accrued Liabilities | $7M | $4M | $3M | |
| Current Liabilities | $8M | $8M | $47M | |
| Capital Leases | $563.0K | $46.0K | $52.0K | |
| Deferred Tax | $883.0K | $883.0K | · | |
| Other Non-current Liabilities | · | $4M | $8.0K | |
| Total Liabilities | $31M | $29M | $47M | |
| Long-term Debt | $21M | $17M | $38M | |
| Common Stock | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $108M | $90M | $2M | |
| Retained Earnings | $-96M | $-71M | $-134M | |
| AOCI | $-99.0K | $1.0K | $17.0K | |
| Stockholders' Equity | $12M | $20M | $-132M | |
| Liabilities + Equity | $43M | $48M | $7M | |
| Shares Outstanding | 22,210,459 | 15,198,232 | 779,908 |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $970.0K | · | $532.0K | |
| Stock-based Comp | $1M | · | $442.0K | |
| Amort. of Intangibles | $0 | · | · | |
| Operating Cash Flow | $-19M | · | $-26M | |
| CapEx | $374.0K | · | $333.0K | |
| Investing Cash Flow | $-374.0K | · | $-340.0K | |
| Stock Issued | $16M | · | · | |
| Financing Cash Flow | $16M | · | $22M | |
| Net Change in Cash | $-3M | · | $-4M |
Bewertung (TTM) 4
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $453.0K | · | |
| Net Income TTM | $-25M | $-21M | · | |
| P/E | -0.7 | -0.0 | · | |
| Earnings Yield | -145.2% | -3024.8% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | · | $132.0K | $254.0K | $26.0K | $78.0K | |
| Cost of Revenue | · | · | $58.0K | $31.0K | $342.0K | $253.0K | · | $414.0K | $682.0K | $542.0K | $334.0K | |
| R&D Expense | $2M | $3M | $2M | $3M | $2M | $4M | · | $1M | $3M | $3M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $3M | $2M | $3M | · | $3M | $3M | $5M | $3M | |
| Operating Expenses | $5M | $5M | $4M | $6M | $5M | $7M | · | $5M | $7M | $9M | $5M | |
| Operating Income | $-5M | $-5M | $-4M | $-6M | $-5M | $-7M | · | $-4M | $-7M | $-9M | $-5M | |
| Interest Income | $72.0K | $107.0K | $132.0K | $79.0K | $102.0K | $164.0K | · | $166.0K | $2.0K | $1.0K | $1.0K | |
| Other Non-op | $-69.0K | $70.0K | $127.0K | $12.0K | $102.0K | $-46.0K | · | $72.0K | $5.0K | $-43.0K | $93.0K | |
| Net Income | $-7M | $-7M | $-3M | $-10M | $-4M | $-8M | · | $4M | $-6M | $-8M | $-9M | |
| EPS (Basic) | $-0.30 | $-0.31 | $-0.09 | $-0.66 | $-0.26 | $-0.50 | · | $0.18 | $-7.35 | $-10.28 | $-11.33 | |
| EPS (Diluted) | $-0.30 | $-0.31 | $0.01 | $-0.66 | $-0.35 | $-0.51 | · | $0.02 | $-7.35 | $-10.28 | $-11.33 | |
| Shares (Basic) | 22,210,459 | 22,210,459 | -29,561,525 | 15,381,565 | 15,381,565 | 15,375,521 | · | 14,057,636 | 779,908 | 779,908 | 325 | |
| Shares (Diluted) | 22,210,459 | 22,210,459 | -29,561,525 | 15,381,565 | 15,381,565 | 15,375,521 | · | 16,057,636 | 779,908 | · | · | |
| EBITDA | $-5M | $-5M | · | $-6M | $-5M | $-7M | · | $-4M | · | · | · |
Bilanz 28
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $13M | $17M | $5M | $8M | $13M | $21M | $28M | · | · | $1M | |
| Receivables | · | · | · | · | · | $1.0K | $35.0K | $90.0K | · | · | $71.0K | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | · | · | $3M | |
| Prepaid Expense | $920.0K | $1M | $989.0K | $1M | $1M | $2M | $2M | $2M | · | · | $232.0K | |
| Other Current Assets | $43.0K | $281.0K | $316.0K | $811.0K | $1M | $507.0K | $222.0K | $213.0K | · | · | $177.0K | |
| Current Assets | $11M | $16M | $20M | $8M | $12M | $17M | $25M | $35M | · | · | $5M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | $1M | |
| PP&E (Gross) | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | · | · | $3M | |
| Accum. Depreciation | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | · | · | $2M | |
| Goodwill | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $44M | · | · | $0 | |
| Intangibles | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $26M | · | · | $0 | |
| Other Non-current Assets | · | $1.0K | $3.0K | $6.0K | $9.0K | $11.0K | $14.0K | $16.0K | · | · | $23.0K | |
| Total Assets | $34M | $39M | $43M | $32M | $36M | $41M | $48M | $107M | · | · | $7M | |
| Accounts Payable | $699.0K | $1M | $1M | $1M | $1M | $3M | $3M | $4M | · | · | $4M | |
| Accrued Liabilities | $7M | $7M | $7M | $8M | $3M | $3M | $4M | $3M | · | · | $3M | |
| Current Liabilities | $8M | $9M | $8M | $10M | $5M | $6M | $8M | $8M | · | · | $47M | |
| Capital Leases | $936.0K | $992.0K | $563.0K | $596.0K | $629.0K | $668.0K | $46.0K | $85.0K | · | · | $52.0K | |
| Deferred Tax | $883.0K | $883.0K | $883.0K | $883.0K | $883.0K | $883.0K | $883.0K | $3M | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $4M | $4M | $4M | $4M | · | · | $8.0K | |
| Total Liabilities | $34M | $34M | $31M | $33M | $27M | $29M | $29M | $31M | $5.0K | · | $47M | |
| Long-term Debt | $25M | $23M | $21M | $21M | $17M | $18M | $17M | $14M | · | · | $38M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | · | · | $1.0K | |
| Paid-in Capital | $109M | $108M | $108M | $91M | $91M | $91M | $90M | $90M | $2M | · | $2M | |
| Retained Earnings | $-109M | $-103M | $-96M | $-92M | $-82M | $-78M | $-71M | $-13M | $-2M | · | $-134M | |
| AOCI | $10.0K | $-143.0K | $-99.0K | $-95.0K | $-99.0K | $-60.0K | $1.0K | $-9.0K | · | · | $17.0K | |
| Stockholders' Equity | $-415.0K | $6M | $12M | $-1M | $9M | $12M | $20M | $77M | $-5.0K | · | $-132M | |
| Liabilities + Equity | $34M | $39M | $43M | $32M | $36M | $41M | $48M | $107M | · | · | $7M | |
| Shares Outstanding | 22,210,459 | 22,210,459 | 22,210,459 | 15,381,565 | 15,381,565 | 15,381,565 | 15,198,232 | 14,535,136 | · | · | 779,908 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $201.0K | $210.0K | $237.0K | $191.0K | $271.0K | $271.0K | · | $316.0K | $257.0K | $330.0K | $133.0K | |
| Stock-based Comp | $479.0K | $389.0K | $890.0K | $137.0K | $234.0K | $218.0K | · | · | $111.0K | $110.0K | $113.0K | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Other Non-cash | · | $2M | · | · | · | $13.0K | · | $-10M | · | · | · | |
| Operating Cash Flow | $-5M | $-4M | $-4M | $-3M | $-5M | $-7M | · | $-6M | $-7M | $-7M | $-7M | |
| CapEx | $6.0K | $2.0K | $-491.0K | $520.0K | $10.0K | $335.0K | · | $578.0K | $175.0K | $162.0K | $20.0K | |
| Investing Cash Flow | $-6.0K | $-2.0K | $491.0K | $-520.0K | $-10.0K | $-335.0K | · | $-578.0K | $-175.0K | $-162.0K | $-20.0K | |
| Financing Cash Flow | · | · | · | · | · | · | · | · | $5M | $10M | $7M | |
| Net Change in Cash | $-5M | $-4M | $12M | $-4M | $-5M | $-8M | · | $-7M | $-2M | $3M | $-598.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-8M | · | $-7M | · | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -3352.3% | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | 2731.8% | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -3112.9% | · | · | · | |
| ROA | -19.3% | -17.3% | · | -14.6% | -22.0% | -37.3% | · | 6.7% | · | · | · | |
| ROE | -162.8% | -77.2% | · | -26.9% | -91.1% | -124.4% | · | 9.4% | 28551.8% | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.8 | · | 0.8 | 2.5 | 2.9 | · | 4.4 | · | · | · | |
| Quick Ratio | 1.0 | 1.5 | · | 0.5 | 1.7 | 2.2 | · | 3.6 | · | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | · | · | · | |
| Inventory Turnover | · | · | · | 0.0 | 0.4 | 0.2 | · | 0.2 | · | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 2.9 | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | · | · | $453.0K | $453.0K | · | $453.0K | · | · | · | |
| Net Income TTM | $-28M | $-29M | · | $-18M | $-14M | $-18M | · | $-21M | · | · | · | |
| Market Cap | $14M | $26M | · | $30M | $20M | $12M | · | $38M | · | · | · | |
| P/E | -0.4 | -0.6 | · | -1.3 | -0.2 | -0.0 | · | -0.1 | · | · | · | |
| P/S | · | · | · | · | 44.1 | 27.3 | · | 82.8 | · | · | · | |
| P/B | -34.9 | 4.5 | · | -22.7 | 2.3 | 1.0 | · | 0.5 | · | · | · | |
| P / Tangible Book | · | · | · | · | · | · | · | 6.0 | · | · | · | |
| P / Cash Flow | · | -6.2 | · | · | · | -1.7 | · | -5.9 | · | · | · | |
| P / FCF | · | -6.2 | · | · | · | -1.6 | · | -5.4 | · | · | · | |
| Earnings Yield | -248.5% | -159.1% | · | -77.3% | -630.0% | -2250.9% | · | -1231.0% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Umsatz | $0 | — | $300.0K |
| Nettoergebnis | $-25M | — | $-37M |
| Verwässerte EPS | $-1.51 | — | $-48.16 |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 25 Einreicher · $9.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 6 (+2 vs. Vorquartal) | 3 (0 vs. Vorquartal) | 4 (0 vs. Vorquartal) | 5 (+3 vs. Vorquartal) | -495K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $6.439.534 | 9.876.586 | 65,50% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $820.039 | 1.258.501 | 8,34% | Aktien |
| ADAR1 Capital Management, LLC | $785.469 | 1.205.447 | 7,99% | Aktien |
| Alyeska Investment Group, L.P. | $755.605 | 1.159.615 | 7,69% | Aktien |
| Sio Capital Management, LLC | $455.461 | 698.989 | 4,63% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $146.193 | 224.360 | 1,49% | Aktien |
| Shaolin Capital Management LLC | $111.534 | 171.170 | 1,13% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $71.038 | 108.954 | 0,72% | Aktien |
| Affinity Asset Advisors, LLC | $52.128 | 80.000 | 0,53% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $39.852 | 61.161 | 0,41% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $35.066 | 53.782 | 0,36% | Aktien |
| VANGUARD GROUP INC | $26.696 | 25.669 | 0,27% | Aktien |
| NORTHERN TRUST CORP | $20.118 | 30.875 | 0,20% | Aktien |
| TORONTO DOMINION BANK | $16.300 | 25.000 | 0,17% | Aktien |
| Opaleye Management Inc. | $13.353 | 18.444 | 0,14% | Aktien |
| XTX Topco Ltd | $11.828 | 18.153 | 0,12% | Aktien |
| CITADEL ADVISORS LLC | $10.527 | 16.155 | 0,11% | Aktien |
| CITIGROUP INC | $8.637 | 13.255 | 0,09% | Aktien |
| BANK OF AMERICA CORP /DE/ | $7.507 | 11.531 | 0,08% | Aktien |
| Tower Research Capital LLC (TRC) | $4.205 | 6.454 | 0,04% | Aktien |
| Crewe Advisors LLC | $326 | 500 | 0,00% | Aktien |
| MORGAN STANLEY | $89 | 137 | 0,00% | Aktien |
| BARCLAYS PLC | $15 | 23 | 0,00% | Aktien |
| HRT FINANCIAL LP | $8 | 13.705 | 0,00% | Aktien |
| UBS Group AG | $1 | 1 | 0,00% | Aktien |
Unternehmensinsider 8 Insider · 2 Führungskräfte · 1 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Olav Bergheim | CEO | 31. Juli 2024 J | 22.081 | 0 | 0 | $0 |
| Hakon Bergheim | Chief Operating Officer | 31. Juli 2024 A | 7.539 | 0 | 0 | $0 |
| Keyvan Mirsaeedi-Farahani | — | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Orly Mishan | — | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Sean Salmon | — | 16. Juni 2026 A | — | 0 | 0 | $0 |
| Timothy P. Moran | — | 16. Juni 2026 A | — | 0 | 0 | $0 |
| James L Cox | — | 16. Juni 2026 A | 36.698 | 0 | 0 | $0 |
| Sandra A. Gardiner | — | 16. Juni 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.